Journal of Diabetes Research

Inflammatory Regulation in Diabetes and Metabolic Dysfunction


Status
Published

1University of Maryland, Baltimore, USA

2Yangtze University, Jingzhou, China

3Nara Hospital Kinki University, Osaka, Japan


Inflammatory Regulation in Diabetes and Metabolic Dysfunction

Description

Diabetes has been considered as a chronic inflammatory disease for decades. Increasing evidence indicates that inflammation plays a critical role in the pathogenesis of both type 1 and type 2 diabetes. Type 1 diabetes is characterized by T cell-mediated autoimmune destruction of pancreatic β cells, while inflammatory responses have been detected in both islets and insulin-sensitive tissues such as adipose tissue, liver, and muscle in type 2 diabetes. This special issue aims at furthering our understanding on the inflammatory regulation in diabetes and metabolic dysfunction.

We invite authors to contribute original research articles as well as review articles that focus on the topic of inflammatory regulation in metabolic dysfunction.

Potential topics include but are not limited to the following:

  • Mechanism regulating inflammation in diabetes
  • Inflammatory markers in the diagnosis of type 1 or type 2 diabetes
  • Clinical immunology in diabetes
  • The role of acute phase proteins and cytokines in metabolic regulation
  • Relationships between inflammation and metabolism
  • Inflammation in organs/tissues (fat, liver, muscle, pancreas, etc.) and insulin resistance
  • Anti-inflammatory agents in diabetes
  • Insulin and glucose metabolism in the modulation of immune cell function
  • The role of metabolites in modulating inflammatory processes
  • Antidiabetic drugs and inflammation
  • Role of immune cells in the development and progression of diabetes

Articles

  • Special Issue
  • - Volume 2017
  • - Article ID 5165268
  • - Editorial

Inflammatory Regulation in Diabetes and Metabolic Dysfunction

Jixin Zhong | Quan Gong | Akira Mima
  • Special Issue
  • - Volume 2017
  • - Article ID 4275851
  • - Review Article

Relationship between Immunological Abnormalities in Rat Models of Diabetes Mellitus and the Amplification Circuits for Diabetes

Yuji Takeda | Tomoko Shimomura | ... | Ichiro Wakabayashi
  • Special Issue
  • - Volume 2017
  • - Article ID 6494795
  • - Review Article

Role of T Lymphocytes in Type 2 Diabetes and Diabetes-Associated Inflammation

Chang Xia | Xiaoquan Rao | Jixin Zhong
  • Special Issue
  • - Volume 2016
  • - Article ID 2543268
  • - Review Article

The Role of HMGB1 in the Pathogenesis of Type 2 Diabetes

Yanan Wang | Jixin Zhong | ... | Boxu Ren
  • Special Issue
  • - Volume 2016
  • - Article ID 7592931
  • - Research Article

IL-6 Promotes Islet β-Cell Dysfunction in Rat Collagen-Induced Arthritis

Huan Jin | Yaogui Ning | ... | Youlian Wang
  • Special Issue
  • - Volume 2016
  • - Article ID 2846570
  • - Review Article

Considerations for Defining Cytokine Dose, Duration, and Milieu That Are Appropriate for Modeling Chronic Low-Grade Inflammation in Type 2 Diabetes

Craig S. Nunemaker
  • Special Issue
  • - Volume 2016
  • - Article ID 7053963
  • - Research Article

Altered Macrophage and Dendritic Cell Response in Mif−/− Mice Reveals a Role of Mif for Inflammatory-Th1 Response in Type 1 Diabetes

Yuriko Itzel Sánchez-Zamora | Imelda Juarez-Avelar | ... | Miriam Rodriguez-Sosa
  • Special Issue
  • - Volume 2016
  • - Article ID 1028401
  • - Research Article

Potential of IL-33 for Preventing the Kidney Injury via Regulating the Lipid Metabolism in Gout Patients

Lihua Duan | Yan Huang | ... | Guixiu Shi
  • Special Issue
  • - Volume 2016
  • - Article ID 8017571
  • - Review Article

Does Hsp60 Provide a Link between Mitochondrial Stress and Inflammation in Diabetes Mellitus?

Joshua Juwono | Ryan D. Martinus
  • Special Issue
  • - Volume 2016
  • - Article ID 7965317
  • - Research Article

Analysis of Inflammatory Mediators in Prediabetes and Newly Diagnosed Type 2 Diabetes Patients

Zhen Wang | Xu-Hui Shen | ... | Bo Li
Journal of Diabetes Research
 Journal metrics
Acceptance rate32%
Submission to final decision68 days
Acceptance to publication26 days
CiteScore5.500
Impact Factor2.965
 Submit

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.